The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Benefit of intensified perioperative chemotherapy within high-risk CINSARC patients with resectable soft tissue sarcomas (CIRSARC).
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
 
Jean-Yves Blay
No Relationships to Disclose
 
Axel Le Cesne
Honoraria - Amgen; Bayer; Lilly; Novartis; Pfizer; PharmaMar
 
Emmanuelle Bompas
No Relationships to Disclose
 
Sophie Piperno-Neumann
No Relationships to Disclose
 
Florence Duffaud
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Carine A. Bellera
No Relationships to Disclose
 
Charles Honoré
No Relationships to Disclose
 
Eberhard Stoeckle
No Relationships to Disclose
 
Sylvie Bonvalot
No Relationships to Disclose
 
Christine Chevreau
Consulting or Advisory Role - BMS , Novartis, Ipsen, Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Pfizer ipsen